Return On Assets of AXIM BIOTECHNOLOGIES, INC. from 31 Dec 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
AXIM BIOTECHNOLOGIES, INC. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2012 to 30 Jun 2024.
  • AXIM BIOTECHNOLOGIES, INC. Return On Assets for the quarter ending 30 Jun 2024 was -105%, a 53% increase year-over-year.
  • AXIM BIOTECHNOLOGIES, INC. annual Return On Assets for 2023 was -196%, a 43% decline from 2022.
  • AXIM BIOTECHNOLOGIES, INC. annual Return On Assets for 2022 was -137%, a 12% increase from 2021.
  • AXIM BIOTECHNOLOGIES, INC. annual Return On Assets for 2021 was -156%, a 176% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -105% +117% +53% 01 Apr 2024 30 Jun 2024
Q1 2024 -137% +24% +15% 01 Jan 2024 31 Mar 2024
Q4 2023 -196% -59% -43% 01 Oct 2023 31 Dec 2023
Q3 2023 -171% +106% +38% 01 Jul 2023 30 Sep 2023
Q2 2023 -222% -21% -10% 01 Apr 2023 30 Jun 2023
Q1 2023 -160% +37% +19% 01 Jan 2023 31 Mar 2023
Q4 2022 -137% +19% +12% 01 Oct 2022 31 Dec 2022
Q3 2022 -276% -188% -214% 01 Jul 2022 30 Sep 2022
Q2 2022 -201% -121% -152% 01 Apr 2022 30 Jun 2022
Q1 2022 -197% -151% -330% 01 Jan 2022 31 Mar 2022
Q4 2021 -156% -99% -176% 01 Oct 2021 31 Dec 2021
Q3 2021 -88% -27% -45% 01 Jul 2021 30 Sep 2021
Q2 2021 -80% -12% -18% 01 Apr 2021 30 Jun 2021
Q1 2021 -46% +91% +67% 01 Jan 2021 31 Mar 2021
Q4 2020 -56% +202% +78% 01 Oct 2020 31 Dec 2020
Q3 2020 -61% +170% +74% 01 Jul 2020 30 Sep 2020
Q2 2020 -68% +227% +77% 01 Apr 2020 30 Jun 2020
Q1 2020 -137% +247% +64% 01 Jan 2020 31 Mar 2020
Q4 2019 -259% +355% +58% 01 Oct 2019 31 Dec 2019
Q3 2019 -231% +409% +64% 01 Jul 2019 30 Sep 2019
Q2 2019 -294% +133% +31% 01 Apr 2019 30 Jun 2019
Q1 2019 -385% -147% -62% 01 Jan 2019 31 Mar 2019
Q4 2018 -614% -459% -296% 01 Oct 2018 31 Dec 2018
Q3 2018 -641% -484% -310% 01 Jul 2018 30 Sep 2018
Q2 2018 -428% -223% -109% 01 Apr 2018 30 Jun 2018
Q1 2018 -238% +302% +56% 01 Jan 2018 31 Mar 2018
Q4 2017 -155% +454% +75% 01 Oct 2017 31 Dec 2017
Q3 2017 -156% +1051% +87% 01 Jul 2017 30 Sep 2017
Q2 2017 -205% +825% +80% 01 Apr 2017 30 Jun 2017
Q1 2017 -540% +76% +12% 01 Jan 2017 31 Mar 2017
Q4 2016 -609% +19% +3% 01 Oct 2016 31 Dec 2016
Q3 2016 -1207% -925% -328% 01 Jul 2016 30 Sep 2016
Q2 2016 -1029% -827% -409% 01 Apr 2016 30 Jun 2016
Q1 2016 -616% -404% -190% 01 Jan 2016 31 Mar 2016
Q4 2015 -628% -503% -400% 01 Oct 2015 31 Dec 2015
Q3 2015 -282% -196% -228% 01 Jul 2015 30 Sep 2015
Q2 2015 -202% +20% +8.9% 01 Apr 2015 30 Jun 2015
Q1 2015 -212% -89% -73% 01 Jan 2015 31 Mar 2015
Q4 2014 -126% -29% -30% 01 Oct 2014 31 Dec 2014
Q3 2014 -86% -57% 01 Jul 2014 30 Sep 2014
Q2 2014 -222% -190% -591% 01 Apr 2014 30 Jun 2014
Q1 2014 -123% -106% -637% 01 Jan 2014 31 Mar 2014
Q4 2013 -97% -79% -460% 01 Oct 2013 31 Dec 2013
Q3 2013 -29%* 01 Jul 2013 30 Sep 2013
Q2 2013 -32% 01 Apr 2013 30 Jun 2013
Q1 2013 -17% 01 Jan 2013 31 Mar 2013
Q4 2012 -17% 01 Oct 2012 31 Dec 2012

AXIM BIOTECHNOLOGIES, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -196% -59% -43% 01 Jan 2023 31 Dec 2023
2022 -137% +19% +12% 01 Jan 2022 31 Dec 2022
2021 -156% -99% -176% 01 Jan 2021 31 Dec 2021
2020 -56% +202% +78% 01 Jan 2020 31 Dec 2020
2019 -259% +355% +58% 01 Jan 2019 31 Dec 2019
2018 -614% -459% -296% 01 Jan 2018 31 Dec 2018
2017 -155% +454% +75% 01 Jan 2017 31 Dec 2017
2016 -609% +19% +3% 01 Jan 2016 31 Dec 2016
2015 -628% -503% -400% 01 Jan 2015 31 Dec 2015
2014 -126% -29% -30% 01 Jan 2014 31 Dec 2014
2013 -97% -79% -460% 01 Jan 2013 31 Dec 2013
2012 -17% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.